Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
14.40
-0.17 (-1.17%)
At close: Jun 18, 2025, 4:00 PM
14.39
-0.01 (-0.07%)
After-hours: Jun 18, 2025, 4:26 PM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 11 analysts that cover Alignment Healthcare stock have a consensus rating of "Buy" and an average price target of $17.45, which forecasts a 21.18% increase in the stock price over the next year. The lowest target is $9 and the highest is $23.
Price Target: $17.45 (+21.18%)
Analyst Consensus: Buy
* Price targets were last updated on May 2, 2025.
Analyst Ratings
The average analyst rating for Alignment Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
Buy | 3 | 4 | 4 | 4 | 4 | 4 |
Hold | 2 | 2 | 3 | 3 | 3 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 9 | 11 | 11 | 11 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | +18.06% | May 2, 2025 |
Baird | Baird | Buy Maintains $17 → $22 | Buy | Maintains | $17 → $22 | +52.78% | Apr 15, 2025 |
Stifel | Stifel | Strong Buy Maintains $18 → $23 | Strong Buy | Maintains | $18 → $23 | +59.72% | Apr 8, 2025 |
JP Morgan | JP Morgan | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | +18.06% | Mar 6, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $14 → $21 | Buy | Maintains | $14 → $21 | +45.83% | Mar 4, 2025 |
Financial Forecast
Revenue This Year
3.88B
from 2.70B
Increased by 43.37%
Revenue Next Year
4.91B
from 3.88B
Increased by 26.55%
EPS This Year
-0.35
from -0.67
EPS Next Year
-0.08
from -0.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.0B | 5.2B | 5.4B | ||
Avg | 3.9B | 4.9B | 5.2B | ||
Low | 3.7B | 4.5B | 4.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 48.5% | 34.2% | 10.1% | ||
Avg | 43.4% | 26.5% | 5.4% | ||
Low | 37.2% | 17.1% | -0.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.28 | 0.11 | 0.45 | ||
Avg | -0.35 | -0.08 | 0.14 | ||
Low | -0.42 | -0.35 | -0.21 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.